News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
200,657 Results
Type
Article (19491)
Company Profile (104)
Press Release (181062)
Multimedia
Podcasts (29)
Webinars (9)
Section
Business (63711)
Career Advice (819)
Deals (9224)
Drug Delivery (73)
Drug Development (18647)
Employer Resources (140)
FDA (3310)
Job Trends (6003)
News (95128)
Policy (7038)
Tag
Academia (1494)
Academic (2)
Accelerated approval (1)
Adcomms (16)
Allergies (18)
Alliances (17335)
ALS (28)
Alzheimer's disease (551)
Antibody-drug conjugate (ADC) (61)
Approvals (3324)
Artificial intelligence (125)
Autoimmune disease (10)
Automation (9)
Bankruptcy (52)
Best Places to Work (4900)
BIOSECURE Act (12)
Biosimilars (49)
Biotechnology (64)
Bladder cancer (26)
Brain cancer (7)
Breast cancer (93)
Cancer (659)
Cardiovascular disease (64)
Career advice (725)
Career pathing (31)
CAR-T (54)
Cell therapy (151)
Cervical cancer (8)
Clinical research (14222)
Collaboration (376)
Compensation (87)
Complete response letters (7)
COVID-19 (957)
CRISPR (22)
C-suite (137)
Cystic fibrosis (40)
Data (649)
Decentralized trials (1)
Denatured (21)
Depression (16)
Diabetes (73)
Diagnostics (2390)
Digital health (6)
Diversity (7)
Diversity, equity & inclusion (37)
Drug discovery (52)
Drug pricing (44)
Drug shortages (4)
Duchenne muscular dystrophy (39)
Earnings (14700)
Editorial (14)
Employer branding (23)
Employer resources (118)
Events (30807)
Executive appointments (403)
FDA (3658)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (364)
Gene editing (41)
Generative AI (14)
Gene therapy (104)
GLP-1 (296)
Government (1316)
Guidances (22)
Healthcare (4982)
Huntington's disease (13)
IgA nephropathy (9)
Immunology and inflammation (27)
Indications (6)
Infectious disease (1014)
Inflammatory bowel disease (58)
Inflation Reduction Act (7)
Influenza (15)
Intellectual property (30)
Interviews (116)
IPO (3820)
IRA (16)
Job creations (1302)
Job search strategy (633)
Kidney cancer (1)
Labor market (35)
Layoffs (163)
Leadership (11)
Legal (1182)
Liver cancer (23)
Lung cancer (97)
Lymphoma (57)
Machine learning (1)
Management (42)
Manufacturing (126)
MASH (13)
Medical device (2684)
Medtech (2688)
Mergers & acquisitions (5643)
Metabolic disorders (210)
Multiple sclerosis (39)
NASH (9)
Neurodegenerative disease (27)
Neuropsychiatric disorders (5)
Neuroscience (742)
NextGen: Class of 2025 (2091)
Non-profit (1672)
Now hiring (38)
Obesity (127)
Opinion (94)
Ovarian cancer (22)
Pain (32)
Pancreatic cancer (13)
Parkinson's disease (42)
Partnered (13)
Patents (53)
Patient recruitment (25)
Peanut (13)
People (27106)
Pharmaceutical (25)
Pharmacy benefit managers (1)
Phase I (4201)
Phase II (5892)
Phase III (5647)
Pipeline (331)
Policy (54)
Postmarket research (558)
Preclinical (2403)
Press Release (61)
Prostate cancer (29)
Psychedelics (18)
Radiopharmaceuticals (63)
Rare diseases (122)
Real estate (2516)
Recruiting (54)
Regulatory (5112)
Reports (35)
Research institute (1262)
Resumes & cover letters (106)
Rett syndrome (1)
RNA editing (2)
RSV (26)
Schizophrenia (25)
Series A (74)
Series B (42)
Service/supplier (8)
Sickle cell disease (23)
Special edition (8)
Spinal muscular atrophy (51)
Sponsored (13)
Startups (1997)
State (1)
Stomach cancer (6)
Supply chain (23)
Tariffs (8)
The Weekly (8)
Vaccines (200)
Venture capitalists (29)
Weight loss (88)
Women's health (12)
Worklife (16)
Date
Today (76)
Last 7 days (294)
Last 30 days (898)
Last 365 days (10402)
2025 (3480)
2024 (11482)
2023 (13077)
2022 (15661)
2021 (17828)
2020 (16465)
2019 (15071)
2018 (10888)
2017 (10373)
2016 (10260)
2015 (11050)
2014 (8156)
2013 (7049)
2012 (7435)
2011 (7628)
2010 (7114)
Location
Africa (323)
Alabama (21)
Alaska (4)
Arizona (68)
Arkansas (4)
Asia (11263)
Australia (1978)
California (1812)
Canada (630)
China (146)
Colorado (94)
Connecticut (66)
Delaware (81)
Europe (29154)
Florida (263)
Georgia (56)
Hawaii (1)
Idaho (11)
Illinois (132)
India (17)
Indiana (147)
Iowa (6)
Japan (69)
Kansas (28)
Kentucky (7)
Louisiana (4)
Maine (6)
Maryland (206)
Massachusetts (1491)
Michigan (94)
Minnesota (114)
Mississippi (1)
Missouri (31)
Montana (5)
Nebraska (9)
Nevada (11)
New Hampshire (14)
New Jersey (568)
New Mexico (16)
New York (686)
North Carolina (342)
North Dakota (8)
Northern California (847)
Ohio (67)
Oklahoma (6)
Oregon (16)
Pennsylvania (312)
Puerto Rico (3)
Rhode Island (8)
South America (391)
South Carolina (5)
Southern California (593)
Tennessee (31)
Texas (229)
United States (7116)
Utah (46)
Virginia (47)
Washington D.C. (23)
Washington State (149)
Wisconsin (36)
200,657 Results for "genuity science".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Marker Therapeutics to Present at Canaccord Genuity’s Horizons in Oncology Conference
April 1, 2025
·
1 min read
Press Releases
Sensei Biotherapeutics to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference
April 2, 2025
·
1 min read
Press Releases
Adicet Bio to Participate in 2025 Canaccord Genuity Horizons in Oncology Virtual Conference
April 1, 2025
·
1 min read
Press Releases
Delcath Systems to Participate at the Canaccord Genuity Horizons in Oncology Virtual Conference
March 24, 2025
·
2 min read
Press Releases
Anika To Present at the Canaccord Genuity 2025 Musculoskeletal Conference
February 26, 2025
·
1 min read
Press Releases
Orthofix to Participate in the Canaccord Genuity 2025 Musculoskeletal Conference
February 17, 2025
·
1 min read
Press Releases
Spine BioPharma, Inc. to Present at the Canaccord Genuity 2025 Musculoskeletal Conference
March 4, 2025
·
1 min read
Press Releases
atai Life Sciences to Participate in the Canaccord Genuity 44th Annual Growth Conference
August 7, 2024
·
1 min read
Business
New Jersey’s Life Sciences Scene Continues Expanding Beyond Big Pharma
Known as the home of big-name companies including Johnson & Johnson, New Jersey has become a destination for more and more small and midsize life sciences businesses. Choose New Jersey, Grace Therapeutics and Onyx Equities executives discuss the state’s life sciences scene.
April 10, 2025
·
6 min read
·
Angela Gabriel
Business
Zevra Therapeutics to Present at Canaccord Genuity’s 44th Annual Growth Conference
August 7, 2024
·
2 min read
1 of 20,066
Next
